Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria)
- PMID: 14512218
- DOI: 10.1016/s0006-3223(03)00113-6
Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria)
Abstract
We report two adult patients with succinic semialdehyde dehydrogenase deficiency, manifesting as gamma-hydroxybutyric aciduria. For both, the clinical presentation included significant behavioral disturbances and psychosis (hallucinations, disabling anxiety, aggressive behavior, and sleep disorder), leading to multiple therapeutic attempts. Intervention with benzodiazepines appeared most efficacious, resulting in decreased aggression and agitation and improvement in anxiety. A review of 56 published and unpublished studies of SSADH-deficient patients revealed that 42% manifested behavioral disturbances, whereas 13% (predominantly adults) displayed psychotic symptomatology. To explore the potential biochemical basis of these behavioral abnormalities, we studied cerebrospinal fluid derived from 13 patients, which revealed significantly elevated GHB (65- to 230-fold), high free and total GABA (up to threefold), and low glutamine. Although within the control range, homovanillic and 5-hydroxyindoleacetic acids (end products of dopamine and serotonin metabolism, respectively) showed a significant linear correlation with increasing GHB concentration, suggesting enhanced dopamine and serotonin turnover. We conclude that elevated GABA combined with low glutamine suggest disruption of the glial-neuronal glutamine/GABA/glutamate shuttle necessary for replenishment of neuronal neurotransmitters, whereas altered dopamine and serotonin metabolism may be causally linked to the hyperkinetic movement disorders and behavioral disturbances seen in SSADH-deficient patients.
Similar articles
-
Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria).J Pharmacol Exp Ther. 2002 Jul;302(1):180-7. doi: 10.1124/jpet.302.1.180. J Pharmacol Exp Ther. 2002. PMID: 12065715
-
4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism.Neuropediatrics. 1998 Feb;29(1):14-22. doi: 10.1055/s-2007-973527. Neuropediatrics. 1998. PMID: 9553943 Review.
-
The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients.Pediatrics. 1997 Apr;99(4):567-74. doi: 10.1542/peds.99.4.567. Pediatrics. 1997. PMID: 9093300
-
Altered cerebral glucose and acetate metabolism in succinic semialdehyde dehydrogenase-deficient mice: evidence for glial dysfunction and reduced glutamate/glutamine cycling.J Neurochem. 2007 Dec;103(5):2077-91. doi: 10.1111/j.1471-4159.2007.04887.x. Epub 2007 Sep 13. J Neurochem. 2007. PMID: 17854388
-
Murine succinate semialdehyde dehydrogenase deficiency.Ann Neurol. 2003;54 Suppl 6:S81-90. doi: 10.1002/ana.10625. Ann Neurol. 2003. PMID: 12891658 Review.
Cited by
-
Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.J Inherit Metab Dis. 2007 Nov;30(6):846-54. doi: 10.1007/s10545-007-0723-7. Epub 2007 Oct 22. J Inherit Metab Dis. 2007. PMID: 17957491 Review.
-
Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (gamma-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1-/- mice and characterization of gamma-hydroxybutyric acid pharmacology.J Inherit Metab Dis. 2007 Jun;30(3):279-94. doi: 10.1007/s10545-007-0574-2. Epub 2007 Apr 24. J Inherit Metab Dis. 2007. PMID: 17457693
-
Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency.Hum Genomics. 2009 Jan;3(2):106-20. doi: 10.1186/1479-7364-3-2-106. Hum Genomics. 2009. PMID: 19164088 Free PMC article. Review.
-
The X-ray crystal structure of Escherichia coli succinic semialdehyde dehydrogenase; structural insights into NADP+/enzyme interactions.PLoS One. 2010 Feb 18;5(2):e9280. doi: 10.1371/journal.pone.0009280. PLoS One. 2010. PMID: 20174634 Free PMC article.
-
Novel QTL at chromosome 6p22 for alcohol consumption: Implications for the genetic liability of alcohol use disorders.Am J Med Genet B Neuropsychiatr Genet. 2014 Jun;165B(4):294-302. doi: 10.1002/ajmg.b.32231. Epub 2014 Apr 1. Am J Med Genet B Neuropsychiatr Genet. 2014. PMID: 24692236 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical